Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of NovoSeven and AryoGen recombinant factor VIIa in congenital factor VII deficiency
IRCT201104266302N1Phase 3Completed
- Sponsor
- AryoGen Biopharma
- Start
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of coagulation factor VIIa in congenital factor VII deficiency (2 arms), sponsored by AryoGen Biopharma. Started Feb 2012; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
congenital factor VII deficiency
Beyond the preview
Go deeper on IRCT201104266302N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201104266302N1.